Rigel Pharmaceuticals | RIGL - Loan Capital

Stock Price
26.29
Daily Change
0.16 0.61%
Monthly
-26.38%
Yearly
38.51%
Q1 Forecast
25.18

Rigel Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in September of 2024.





Loan Capital Change Date
Agenus USD 169.66M 146.06M Dec/2025
Amgen USD 50B 2.43B Dec/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Heron Therapeutics USD 140.64M 975K Dec/2025
Intrexon USD 0 198.67M Jun/2024
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
MacroGenics USD 70M 256K Dec/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Veracyte USD 0 0 Mar/2025